Adoption of new therapies in the treatment of hepatitis: a verification of the accuracy of Budget Impact Analysis to guide investment decisions

CONCLUSION: This study demonstrates appreciable divergence (US$156.58 million) between the theoretical budget impact and RWE expenditures due to underestimated purchase prices and overestimated populations. The greater the degree of accuracy the more reliable and usable BIAs become for decision making.PMID:35320682 | DOI:10.1080/14737167.2022.2057950

Source: Expert Review of Pharmacoeconomics and Outcomes Research - March 23, 2022 Category: Health Management Authors: Daniel Resende Faleiros Everton Nunes da Silva Andreia C Santos Brian B Godman Ramon Goncalves Pereira Augusto A Guerra Junior Source Type: research